Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000011960
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Type I diabetes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement of endothelial function
- Secondary Outcome Measures
Name Time Method HbA1c,Glycated albumin,1.5-anhydro-D-glucitol,fasting plasma glucose, immunoreactive insulin, HOMA-IR, HOMA-beta, hs-CRP, IL-6, MCP-1, TNF-alpha Red blood cell, White blood cell, platelet, D dimer, FDP, fibrinogen, 8-OHdG, BNP, body weight